Cornea warming during laser treatment

Article

A small case study looking at cornea temperature rise during laser treatment using a new 'Intelligent Thermal Effect Control'

This is the result of scientific thermodynamic measurements carried out at the Eye Laser Clinic Recklinghausen, Germany (Diego de Ortueta, MD) by the University of Applied Sciences, Aschaffenburg.

Seven myopic eyes were investigated with preoperative spherical equivalent (SEQ) ranging from –2.75 to –9.25 dioptres. The measurements were performed with a high-resolution infrared thermographic camera that recorded thermal images of the eye at a rate of one time per second from a distance of 66 cm. Cornea temperature rise was evaluated within the optical zone as well as in the entire ablation zone.

So what is the method?

"The measurement results give me even more safety for treatment of higher myopes," commented Dr Diego de Ortueta, one of the researchers at the Eye Laser Clinic Recklinghausen. "The high pulse frequency of the Scwhind Amaris allows a very short treatment time without significantly warming the corneal tissue."

References

1. T. Bende, T. Seiler and J. Wollensak, Graefe's Arch. Clin. Exp. Ophthalmol., 1988;226:277–280.

2. M. Ishihara et al., Lasers Surg. Med., 2002;30(1):54–59.

3. S. Betney et al., Cornea. 1997;16(2):158–161.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.